This bill proposes the repeal of RSA 126-Q, which pertains to the New Hampshire Vaccine Association (NHVA). The repeal will eliminate the NHVA's role in collecting payments from approximately 80 commercial payers and third-party administrators, which are currently used to reimburse the Department of Health and Human Services for the non-governmental share of the state's universal vaccine purchasing program for children. As a result of this repeal, the state anticipates a decrease in annual revenue of $24 million, which will also correspond to a decrease in state expenditures since provider sites will need to independently purchase and manage immunization inventories for privately-insured patients under the age of 19.

The bill does not authorize any new funding or positions, but it does indicate that the Department of Health and Human Services may require temporary part-time staff to communicate the changes to providers, costing an estimated $44,000 in FY26. Additionally, the Department will need to allocate funds for vaccine purchases during public health emergencies, estimated at $150,000 in FY26 and $100,000 in subsequent years. The Insurance Department warns that the repeal could lead to increased healthcare costs for insurers, as they may lose access to savings currently provided by the NHVA, potentially resulting in higher insurance premiums and increased insurance premium tax revenue.